Navigating Ollier Disease: A Comprehensive Guide for Families
At a Glance
Ollier disease is a rare, non-inherited skeletal disorder that causes benign cartilage tumors (enchondromas) to grow inside bones. Managing the condition involves orthopedic treatments to correct bone growth and lifelong monitoring to watch for malignant transformation.
Ollier disease is a rare, non-hereditary skeletal disorder characterized by the presence of multiple enchondromas—benign tumors made of cartilage that grow within the bones [1][2]. A diagnosis can be overwhelming, but this guide is designed to empower you with evidence-based information to help you manage the condition and advocate for the best possible care.
The information in this resource is divided into focused sections to help you navigate different aspects of the disease, from initial diagnosis to long-term management.
Finding Your Footing: A Guide for New Ollier Disease Families
Start here if you or your child has recently been diagnosed. This section covers the foundational facts of the disease, addressing immediate fears and outlining what to expect in the coming weeks and months.
Recognizing Symptoms and Watching for Warning Signs
Learn how to identify the common orthopedic challenges of Ollier disease, such as limb length discrepancies and bowing. More importantly, this page details the critical “red flags”—like pain at rest—that require immediate medical attention.
The Biology of a 'Glitch': Genetics and Diagnosis
Understand the science behind the condition. This section explains the concept of somatic mosaicism, the specific genetic mutations (IDH1 and IDH2) involved, and how Ollier disease differs from related conditions like Maffucci syndrome [3][4].
Correcting and Managing Bone Growth Challenges
Explore the orthopedic solutions available to keep patients mobile and active. This page compares traditional external fixators with modern internal lengthening nails and discusses how to manage pathological fractures.
Long-term Monitoring and Managing Malignancy Risk
Because Ollier disease carries a lifelong risk of malignant transformation, proactive monitoring is essential [5]. This section translates current expert surveillance guidelines into an actionable plan and offers strategies to manage “scanxiety.”
Common questions in this guide
What is Ollier disease?
What are the warning signs and symptoms of Ollier disease?
Is Ollier disease genetic or inherited?
How are the bone growth issues in Ollier disease treated?
Why do patients with Ollier disease need lifelong monitoring?
What specialists should be on our Ollier disease care team?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my/my child's specific case, what specialists should we include in our core care team?
- 2.How frequently should we be scheduling clinical exams compared to imaging?
- 3.Is there a patient navigator or psychosocial support specialist affiliated with this clinic who has experience with rare bone diseases?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (5)
- 1
Teaching NeuroImage: Histopathologically Confirmed Intracranial Enchondroma/Low-Grade Chondrosarcoma and IDH1-Mutated Diffuse Glioma in Ollier Disease.
Gregory TA, Taylor LP
Neurology 2021; (97(17)):e1747-e1748 doi:10.1212/WNL.0000000000012269.
PMID: 34039720 - 2
Ollier Disease: A Case Series and Literature Review.
Markevičiūtė V, Markevičiūtė MŠ, Stravinskas M
Acta medica Lituanic 2021; (28(1)):181-188 doi:10.15388/Amed.2021.28.1.8.
PMID: 34393643 - 3
Update on the imaging features of the enchondromatosis syndromes.
Sharif B, Lindsay D, Saifuddin A
Skeletal radiology 2022; (51(4)):747-762 doi:10.1007/s00256-021-03870-0.
PMID: 34302201 - 4
Gene of the month: IDH1.
Bruce-Brand C, Govender D
Journal of clinical pathology 2020; (73(10)):611-615 doi:10.1136/jclinpath-2020-206813.
PMID: 32727816 - 5
Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes.
Michaeli O, Kim SY, Mitchell SG, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research 2025; (31(3)):457-465 doi:10.1158/1078-0432.CCR-24-2171.
PMID: 39601780
This guide is for informational purposes only and does not replace professional medical advice. Always consult your orthopedic specialist and care team about your specific diagnosis and treatment plan.
Get notified when new evidence is published on Ollier disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.